SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

It’s a journey of ups and downs for IJJ CORPORATION (OTCMKTS:IJJP) as it earned back its bullish rally yesterday. While there has been no information, in particular, to prompt the rally in the stock of IJJ CORPORATION (OTCMKTS:IJJP), but it points out that investors are making their minds about the company.

Up and down

In its very last press release, the company informed its shareholders about the coverage initiated by Wealthmarkers.com, a Wall Street research, and trading firm. As per the coverage, the research firm mentioned that the share value of the company is undervalued. It added that IJJ CORPORATION (OTCMKTS:IJJP) had crossed its Squeeze Trigger price of $0.0029. The company’s stock hit volatility after the coverage was initiated.

It seems that the coverage has come to rescue IJJ CORPORATION (OTCMKTS:IJJP) to a certain extent. The stock of the company traded up by 12.50% to $0.00180 during the last trading session, pumping hope for the company. The rally on Wednesday has helped the company to boast its big gains after it appreciated by nearly 300% in February. The story of the company has been bit shaky as its efforts to date has delivered mixed results. Alongside reporting coverage of Wealthmakers.com, IJJ CORPORATION (OTCMKTS:IJJP) also informed about the reduction in its authorized shares, which is now down by 500 million to 2.5 billion. The said announcement had little impact on investors as even after reduction of authorized shares; the company has a lot number of outstanding shares left with it.

Financial report

Separately, the company had released its first quarter financial report last week. As per the report, IJJ CORPORATION (OTCMKTS:IJJP) achieved the profit despite lower revenues. A deeper look into the reports indicates that the profit was largely because of excessively low expenses than anything else. The company reported just $1,000 per month for expenses, which is way below the expenditure of any profitable company.

IJJ CORPORATION (OTCMKTS:IJJP) closed at $0.00180 in its last trading session.